
The pharma policy bomb retail ignores: How FDA fast-track designations telegraph 10-25% moves weeks before Wall Street reports them
The Food and Drug Administration’s January 16 fast-track designation for Eli Lilly’s experimental Alzheimer’s drug donanemab triggered a 14.7% stock…









